Chemoinformaics analysis of (8E,10E)-7,12-dioxooctadeca-8,10-dienoic acid
Molecular Weight | 308.418 | nRot | 14 |
Heavy Atom Molecular Weight | 280.194 | nRig | 5 |
Exact Molecular Weight | 308.199 | nRing | 0 |
Solubility: LogS | -4.196 | nHRing | 0 |
Solubility: LogP | 3.476 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 51.9382 |
nHD | 1 | BPOL | 30.6938 |
QED | 0.296 |
Synth | 2.496 |
Natural Product Likeliness | 0.833 |
NR-PPAR-gamma | 0.97 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.42 |
Pgp-sub | 0 |
HIA | 0.02 |
CACO-2 | -5.017 |
MDCK | 0.0000414 |
BBB | 0.025 |
PPB | 0.919836 |
VDSS | 0.494 |
FU | 0.0220684 |
CYP1A2-inh | 0.238 |
CYP1A2-sub | 0.154 |
CYP2c19-inh | 0.185 |
CYP2c19-sub | 0.059 |
CYP2c9-inh | 0.369 |
CYP2c9-sub | 0.998 |
CYP2d6-inh | 0.032 |
CYP2d6-sub | 0.874 |
CYP3a4-inh | 0.035 |
CYP3a4-sub | 0.041 |
CL | 1.515 |
T12 | 0.875 |
hERG | 0.033 |
Ames | 0.227 |
ROA | 0.034 |
SkinSen | 0.928 |
Carcinogencity | 0.454 |
EI | 0.936 |
Respiratory | 0.668 |
NR-Aromatase | 0.089 |
Antiviral | Yes |
Prediction | 0.624976 |